Nektar Therapeutics
NKTR
#4801
Rank
S$2.65 B
Marketcap
S$78.46
Share price
2.97%
Change (1 day)
562.06%
Change (1 year)

EPS for Nektar Therapeutics (NKTR)

EPS in 2025 (TTM): S-$13.28

According to Nektar Therapeutics 's latest financial reports the company's current EPS (TTM) is S-$13.09. In 2024 the company made an earnings per share (EPS) of S-$11.37 an increase over its 2023 EPS that were of S-$28.10.

EPS history for Nektar Therapeutics from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S-$13.2816.83%
2024S-$11.37-59.54%
2023S-$28.10-25.89%
2022S-$37.92-31.12%
2021S-$55.0514.86%
2020S-$47.93-1.19%
2019S-$48.50-163.96%
2018S$75.84-725.4%
2017S-$12.13-42.73%
2016S-$21.1783.33%
2015S-$11.5539.53%
2014S-$8.28-69.29%
2013S-$26.95-6.67%
2012S-$28.87

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.21-185.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$1.68-112.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$18.58-241.96%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
S-$2.73-79.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$4.56-134.88%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$8.92-168.14%๐Ÿ‡ฌ๐Ÿ‡ง UK
Richardson Electronics
RELL
S$0.08982-100.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Alkermes
ALKS
S$1.19-109.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland